D. Schiff

机构：University of Virginia

发表论文 10 篇 · 总被引 286 次 · h-index 6

代表论文

A phase II, randomized, non-comparative clinical trial of the effect of bevacizumab (BV) alone or in combination with irinotecan (CPT) on 6-month progression free survival (PFS6) in recurrent, treatment-refractory glioblastoma (GBM) (2008 · Journal of Clinical Oncology · 被引 145)
Phase II study of XL184 (BMS 907351), an inhibitor of MET, VEGFR2, and RET, in patients (pts) with progressive glioblastoma (GB). (2010 · Journal of Clinical Oncology · 被引 65)
Phase II study of AMG 102, a fully human neutralizing antibody against hepatocyte growth factor/scatter factor, in patients with recurrent glioblastoma multiforme (2008 · Journal of Clinical Oncology · 被引 24)
Radiological Aspects of Intra-uterine Blood Transfusion (1967 · British Journal of Radiology · 被引 18)
Phase II study of CT-322, a targeted biologic inhibitor of VEGFR-2 based on a domain of human fibronectin, in recurrent glioblastoma (rGBM). (2010 · Journal of Clinical Oncology · 被引 15)
ANG1005: Results of a phase I study in patients with recurrent malignant glioma. (2010 · Journal of Clinical Oncology · 被引 13)